{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":26,"n_cols":5,"rows_kept":26,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[13,2,13,3],[14,2,14,3],[17,2,17,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910502989103321"]
[null,null,"Titolo",null,"Cardiovascular disease in racial and ethnic minority populations / / edited by Keith C. Ferdinand, Herman A., Jr. Taylor, Carlos J. Rodriguez"]
[null,null,"Pubbl/distr/stampa",null,"Cham, Switzerland : , : Springer, , [2021]"]
[{"$nulls":4},"©2021"]
[null,null,"ISBN",null,"3-030-81034-8"]
[null,null,"Edizione",null,"[2nd ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (244 pages)"]
[null,null,"Collana",null,"Contemporary Cardiology"]
[null,null,"Disciplina",null,"616.1"]
[null,null,"Soggetti",null,"Minorities - Health and hygiene"]
[{"$nulls":4},"Malalties cardiovasculars"]
[{"$nulls":4},"Minories"]
[{"$nulls":4},"Llibres electrònics"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Intro -- Preface -- References -- Contents -- Contributors -- 1: Overview and Perspectives: Cardiovascular Disease in Racial/Ethnic Minorities in the Era of COVID-19 -- Introduction -- Introduction to Precision Medicine: Minority Populations and Cardiovascular Health -- Lipoprotein(a): A Cardiovascular Risk Factor Affecting Ethnic Minorities -- Emerging Precision Medicine Concepts and Cardiovascular Health in African Americans and Hispanics -- The Implementation Frontier: Impact on Cardiovascular Health in Racial and Ethnic Minority Populations -- Genomic Approaches to Hypertension -- Heart Failure in African Americans and Hispanic Americans: A Persistent and Disproportionate Burden in Underrepresented Minorities -- Heterogeneity, Nativity, and Disaggregation of Cardiovascular Risk and Outcomes in Hispanic Americans -- Cardiovascular Epidemiology in Hispanics/Latinos: Lessons Learned from HCHS/SOL -- Lessons Learned from the Jackson Heart Study (JHS) -- Cardiovascular Disease Risk Factors in the Hispanic/Latino Population -- Progress in ASCVD Risk Assessment in African American and Hispanics -- Cardiovascular Disease in Minorities: Unique Considerations Hypertension in African and Hispanic Americans -- Weight Loss, Lifestyle, and Dietary Factors in CVD in African Americans and Hispanics -- Coronary Calcium Scoring in African American and Hispanic Patients -- Epidemiology CVD in African Americans -- Cardiac Amyloid Heart Disease in Racial/Ethnic "]
[{"$nulls":4},"Minorities: Focus on Transthyretin Amyloid Cardiomyopathy -- Imaging for the Assessment and Management of Cardiovascular Disease in Women and Minority Populations -- References -- 2: Introduction to Precision Medicine: Minority Populations and Cardiovascular Health -- An Introduction to Genomic Testing -- Diagnostic Genetic Testing for Heart Disease -- Advances in Genetic Testing."]
[{"$nulls":4},"Development of Genetic Tests as an Evidence-Based Process -- Lack of Diversity in Genetic Research and the Missing Evidence Supporting Generalizability of Genetic Tests -- Impaired Discovery of Genetic Causes in Minority Populations -- Misdiagnosis of Genetic Conditions in Minority Populations -- Unclear Treatment Response in Minority Populations -- Unclear Validity and Utility of Individual Genetic Tests in Minority Populations -- Understanding the Personal Utility of Genetic Tests in Minority Populations -- Access to Precision Medicine and the Health Disparities -- On the Horizon -- The Road Forward -- References -- 3: Lipoprotein(a): A Cardiovascular Risk Factor Affecting Ethnic Minorities -- Introduction to Lipoprotein(a) -- References -- 4: Emerging Precision Medicine Concepts and Cardiovascular Health in African Americans and Hispanics -- Introduction -- Race, Ethnicity, and Genetic Ancestry -- The Lack of Diversity in Genomics Research Resources -- Misclassification of Benign Variants as Genetic Misdiagnosis -- Polygenic Risk Scores and the Potential to Exacerbate Health Disparities -- Trust and Patient Engagement -- Conclusion -- References -- 5: The Implementation Frontier: Impact on Cardiovascular Health in Racial and Ethnic Minority Populations -- Introduction -- Implementation Challenges -- Hypertension Treatment and Control -- Cardiac Catheterization and Invasive Coronary Procedures -- Utilization of Structural Heart Disease Interventions -- Prevention and Treatment of Heart Failure -- Anticoagulation in Atrial Fibrillation -- The Role for Diverse Actors in the Implementation Context -- Research Implications -- Conclusion -- References -- 6: Genomic Approaches to Hypertension -- Introduction -- Primer on Genomic Approaches of HTN -- The Genomic Variants in Blood Pressure Regulation Cause Rare Familial Hypertensive Syndromes."]
[{"$nulls":4},"Key Features of Monogenic HTN -- Mechanistic Pathways of the Monogenic HTN Genes -- Genome-Wide Association Studies and HTN -- Perspectives from the Discovery of Genetic Variants for Essential HTN by GWAS -- Exome Arrays for Discovery of Rare Variants Contributing to BP Regulation -- Conclusion -- References -- 7: Heart Failure in African Americans and Hispanic Americans: A Persistent and Disproportionate Burden in Underrepresented Minorities -- Introduction -- Defining Heart Failure -- Defining the Populations -- Hispanic American -- Black/African American -- Epidemiology -- Risk Factors -- Diet Types and Risk of Heart Failure -- The Curious Case of Hypertension in Black Americans -- American Heart Association 2020 Strategic Plan -- Heart Failure with Reduced and Preserved Ejection Fractions -- Hospitalizations and Readmissions -- Heart Failure Treatment -- Angiotensin Converting Enzyme Inhibitors -- Racial Differences in Response to Renin-Angiotensin-Aldosterone System Inhibition -- Angiotensin II Receptor Blockers -- Angiotensin-Receptor Blocker/Neprilysin Inhibitor (ARNI) -- Beta-Adrenergic Blockers -- Aldosterone Receptor Antagonist -- Heart Failure Treatment in African Americans -- Devices-Implantable Cardiac Defibrillators (ICD) -- Racial Disparities in ICD -- Advanced Heart Failure Therapies -- Heart Transplantation -- Heart Transplants in African Americans and Hispanic Americans -- Left Ventricular Assist Device (LVAD) -- Cardiomyopathies -- Hypertensive Heart Disease -- Cardiac Amyloidosis -- Conclusion -- References -- 8: Heterogeneity, "]
[{"$nulls":4},"Nativity, and Disaggregation of Cardiovascular Risk and Outcomes in Hispanic Americans -- Introduction -- Who Is Hispanic? US Census History -- Hispanic Immigration in the United States -- The Hispanic Paradox -- Healthy Migrant and Statistical Immortality -- Genetics and Healthier Behaviors."]
[{"$nulls":4},"Residence in Ethnic Enclaves -- Acculturation -- Socioeconomic Status -- Heterogeneity and Disaggregation of Cardiovascular Risk in Hispanic Americans -- Risk Factors -- Risk Assessment -- CVD Outcomes -- Emerging Concepts and Future Directions -- Conclusion -- References -- 9: Cardiovascular Epidemiology in Hispanics/Latinos: Lessons Learned from HCHS/SOL -- The Hispanic/Latino Horizon -- Cultural and Psychosocial Spectrum -- Sociodemographic Factors -- Language -- Acculturation -- Education -- Cardiovascular Risk Factors Among Hispanics -- Hypercholesterolemia -- Hypertension -- Obesity, BMI, Physical Activity, and Nutrition -- Diabetes Mellitus and Metabolic Syndrome -- Smoking -- Established Cardiovascular Disease -- Coronary Heart Disease (CHD) -- Stroke -- Peripheral Vascular Disease (PVD) -- Lessons Learned from SOL -- The Hispanic Paradox -- A Call for Action -- References -- 10: Lessons Learned from the Jackson Heart Study -- Introduction -- Rationale Supporting the Decision to Establish the Jackson Heart Study -- Lessons Learned Related to Cardiovascular Disease in the Jackson Heart Study -- Traditional and Novel Risk Factors in the Jackson Heart Study -- Hypertension -- Obesity -- Diabetes and Metabolic Syndrome -- Hypercholesterolemia -- Cigarette Smoking -- Physical Inactivity and Diet -- Cardiovascular Health Score in the Jackson Heart Study -- Biomarkers Relation to Cardiovascular Disease Risk Factors and Subclinical Disease -- Aortic Stiffness and Endothelial Dysfunction -- Subclinical Disease Prevalence and Associated Risk of Cardiovascular Events -- Predictors of Left Ventricular Mass Progression and Cardiovascular Outcomes -- Predictive Models for Cardiovascular Events Based on the JHS Cohort -- Social Determinants of Cardiovascular Disease in the Jackson Heart Study -- Genomics and Proteomics Studies -- Introduction."]
[{"$nulls":4},"Genome of JHS Participants -- Admixture Mapping and Discovery of Genetic Variants Associated with CVD Traits in AA -- Neutropenia -- Lipoprotein Lipase Lp(a) -- Blood Pressure -- Gene-Lifestyle Interactions -- Selected Candidate Gene Analysis -- Replication of Genetic Variants with High Impact Findings -- Future Directions -- References -- 11: Cardiovascular Disease Risk Factors in the Hispanic/Latino Population -- Introduction -- Metabolic Syndrome -- Metabolic Syndrome in  US Hispanics/Latinos -- Hypertension -- Dyslipidemia -- Type 2 Diabetes Mellitus -- Obesity -- The Hispanic/Latino Paradox -- The Puerto Rican Disadvantage -- References -- 12: Progress in ASCVD Risk Assessment in African Americans and Hispanic Americans -- Introduction -- Initial ASCVD Risk Estimation in Populations -- Key Risk Factors for ASCVD Event Prediction -- ASCVD Risk Score Algorithms -- Beyond Traditional Risk Factors for ASCVD -- Summary -- References -- 13: Cardiovascular Disease in Minorities: Unique Considerations: Hypertension in African and Hispanic Americans -- Introduction -- Hispanic Americans -- Pathophysiology -- Hypertension Categorization -- Impact of Hypertension Prevalence and Management -- Treatment for Hypertension -- Public Health Perspectives and Future Considerations -- Conclusion -- References -- 14: Weight Loss, Lifestyle, and Dietary Factors in Cardiovascular Disease in African Americans and Hispanics -- Introduction -- Association of Lifestyle Behaviors with CVD Risk -- Differences in Lifestyle Behaviors by Race/Ethnicity -- Changes in Lifestyle Behaviors Can Improve Risk "]
[{"$nulls":4},"and Prevent CVD -- Evidence That Key Dietary Patterns Are Associated with Lower Risk of CVD -- Food Groups and Risk of CVD -- Dietary Patterns -- Vegetarian Dietary Patterns and CVD -- Dietary Approaches to Stop Hypertension (DASH) Diet."]
[{"$nulls":4},"Dietary Approaches to Stop Hypertension-Sodium."]